Q3 2017 13F Holders as of 30 Sep 2017
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
46.1M
-
Number of holders
-
102
-
Total 13F shares, excl. options
-
22.5M
-
Shares change
-
+294K
-
Total reported value, excl. options
-
$435M
-
Value change
-
+$6.51M
-
Number of buys
-
38
-
Number of sells
-
-47
-
Price
-
$19.35
Significant Holders of Axogen, Inc. - Common Stock, $0.01 par value (AXGN) as of Q3 2017
111 filings reported holding AXGN - Axogen, Inc. - Common Stock, $0.01 par value as of Q3 2017.
Axogen, Inc. - Common Stock, $0.01 par value (AXGN) has 102 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.5M shares
of 46.1M outstanding shares and own 48.78% of the company stock.
Largest 10 shareholders include Essex Woodlands Health Ventures, Inc. (4.86M shares), Opaleye Management Inc. (1.97M shares), BlackRock Inc. (1.38M shares), VANGUARD GROUP INC (1.27M shares), DRIEHAUS CAPITAL MANAGEMENT LLC (681K shares), NEXT CENTURY GROWTH INVESTORS LLC (657K shares), Bank of New York Mellon Corp (632K shares), Russell Investments Group, Ltd. (583K shares), GILDER GAGNON HOWE & CO LLC (564K shares), and PERKINS CAPITAL MANAGEMENT INC (540K shares).
This table shows the top 102 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.